-
May 14, 2012
Scripps Florida Scientists Awarded $8.4 Million Grant to Develop New Anti-Smoking Treatments
Scientists from the Florida campus of The Scripps Research Institute have been awarded an $8.4 million grant from the National Institute on Drug Abuse of the National Institutes of Health (NIH) to develop new compounds to help prevent relapse in smokers who are kicking the habit.
-
May 09, 2012
Scripps Florida Scientists Identify Neurotransmitters that Lead to Forgetting
While we often think of memory as a way of preserving the essential idea of who we are, little thought is given to the importance of forgetting to our wellbeing, whether what we forget belongs in the “horrible memories department” or just reflects the minutia of day-to-day living.
-
May 04, 2012
Noted Scientist Joins Scripps Research Neuroscience Faculty
The Scripps Research Institute has appointed Srini Subramaniam, PhD, as an assistant professor in the Department of Neuroscience.
-
April 26, 2012
Scripps Florida Scientist Awarded $1.5 Million to Design Therapeutics with New RNA Approach
A scientist from the Florida campus of The Scripps Research Institute has been awarded $1.5 million from the National Institutes of Health to develop new computer-driven design methods to find new therapeutics targeting RNA.
-
April 20, 2012
Scripps Florida Scientist Awarded $1 Million for Stress-Associated Disease and Aging Research
A scientist from the Florida campus of The Scripps Research Institute has been awarded just over $1 million from the National Institutes of Health to develop a range of new tests that could lead to new treatments for a number of stress-associated and degenerative disorders of advancing age.
-
April 04, 2012
Scripps Florida Scientist Awarded $1 Million Grant to Develop New Tools for Hepatitis C Treatment Discovery
Scientists from the Florida campus of The Scripps Research Institute have been awarded just over $1 million from the National Institutes of Health for a three-year study to develop new high-throughput screening tests to find compounds that disable a protein essential to hepatitis C virus (HCV) replication.
-
April 02, 2012
Scripps Florida Scientists Shed Light on Age-Related Memory Loss and Possible Treatments
Scientists from the Florida campus of The Scripps Research Institute have shown in animal models that the loss of memory that comes with aging is not necessarily a permanent thing.
-
March 30, 2012
Scripps Florida Scientists Win $2 Million to Study New Pathway Important in the Development and Maintenance of Lymphoma
The National Institutes of Health has awarded The Scripps Research Institute $2 million to study the role of a pathway in the development and maintenance of B-cell lymphoma, a type of cancer that begins in immune system and turns normal disease fighting cells into cancers. The disease affects immune cells known as lymphocytes, which are part of our white blood cells.
-
March 29, 2012
Scripps Research Institute Scientists Create Compounds that Dramatically Alter Biological Clock and Lead to Weight Loss
Scientists from the Florida campus of The Scripps Research Institute have synthesized a pair of small molecules that dramatically alter the core biological clock in animal models, highlighting the compounds’ potential effectiveness in treating a remarkable range of disorders—including obesity, diabetes, high cholesterol, and serious sleep disorders.
-
March 08, 2012
Scripps Research Institute and OPKO Health Announce Global License Agreement for a Novel Compound That Blocks Brain Cell Destruction in Parkinson’s Disease
The Scripps Research Institute and OPKO Health, Inc. (NYSE: OPK) today announced a global agreement for the development and commercialization of SR 3306, a novel compound discovered by scientists from the Florida campus of The Scripps Research Institute that blocks the destruction of brains cells in animal models of Parkinson’s disease
-
March 08, 2012
NIH Executive Selected to Head Scientific Operations for Scripps Florida
The Scripps Research Institute has named Dawn Johnson, PhD, currently with the National Institutes of Health (NIH), as senior director of scientific operations for the Scripps Florida campus.
-
March 06, 2012
Scripps Florida Scientists Share $3.85 Million NIH Grant to Develop New Class of Cancer Therapies
A pair of Scripps Research Institute scientists, one a cancer biologist and the other a chemist, has been awarded $3.85 million from the National Institutes of Health (NIH) to develop a new generation of broad spectrum anti-cancer therapeutics, including breast cancer and lymphoma.
-
February 29, 2012
Scripps Florida Scientists Awarded $3 Million to Develop New, More Effective Pain Treatments
Scripps Florida scientists have been awarded $3.1 million by the National Institute on Drug Abuse, part of the National Institutes of Health, to study and develop several new compounds that could prove to be effective in controlling pain without the unwanted side effects common with opiate drugs, such as morphine, Oxycontin®, and Vicoden®.
-
February 27, 2012
MEDIA ALERT
SCRIPPS FLORIDA HELPS MARK RARE DISEASE DAY - The Scripps Research Institute will mark Rare Disease Day by hosting an event with proclamations from Office of the Governor, Palm Beach County, and the City of Jupiter.
-
February 24, 2012
Scripps Florida Team Awarded Nearly $1.5 Million to Develop Potent New HIV Inhibitors
A Scripps Florida team has been awarded nearly $1.5 million by the National Institutes of Health to identify and develop novel potent inhibitors of the human immunodeficiency virus (HIV), the cause of AIDS.
-
February 23, 2012
Scripps Florida Scientists Uncover Inflammatory Circuit That Triggers Breast Cancer
Although it’s widely accepted that inflammation is a critical underlying factor in a range of diseases, including the progression of cancer, little is known about its role when normal cells become tumor cells.
-
February 22, 2012
Scripps Research Scientists Create Potent Molecules Aimed at Treating Muscular Dystrophy
While RNA is an appealing drug target, small molecules that can actually affect its function have rarely been found.
-
February 09, 2012
Scripps Research Scientists Identify Most Lethal Known Species of Prion Protein
Scientists from the Florida campus of The Scripps Research Institute have identified a single prion protein that causes neuronal death similar to that seen in “mad cow” disease, but is at least 10 times more lethal than larger prion species.
-
February 08, 2012
Scripps Research Licenses New Instrumentation Platform That Dramatically Improves Compound Management
Breakthrough Technology Fills Need for Cost-Effective Quality Oversight of Compounds used for High-Throughput Screening
-
January 31, 2012
An Intriguing Combination in the Brain May Modify Our Appetites, Alter Other Key Processes
The interaction between a disparate pair of brain proteins may have a profound effect on the regulation of appetite, according to a new study by scientists from the Florida campus of The Scripps Research Institute.
-
January 25, 2012
Scripps Research Institute Names Peter K. Vogt as Senior Vice President for Scientific Affairs
The Scripps Research Institute has named Professor Peter K. Vogt, PhD, as senior vice president for scientific affairs.
-
January 17, 2012
Scripps Research Scientists Create Novel RNA Repair Technology
Scientists from the Florida campus of The Scripps Research Institute have identified a compound that can help repair a specific type of defect in RNA, a type of genetic material
-
January 10, 2012
Scripps Research Scientists Paint New Picture of Dance Between Protein and Binding Partners
New Findings Could Influence Design of Future Diabetes Treatments
-
January 04, 2012
Scripps Research Scientist Wins Pair of Grants to Study Critical Component of Memory
Sathyanaryanan Puthanveettil, an assistant professor on the Florida campus of The Scripps Research Institute, has been awarded a pair of notable grants to study a critical component of long-term memory formation.
-
January 02, 2012
Michael A. Marletta Takes Office as New President of Scripps Research Institute
Renowned biochemist Michael A. Marletta, PhD, assumed the post of president and CEO of The Scripps Research Institute January 1, succeeding Richard A. Lerner, MD, who led the institution for more than two decades.